RNA5SP33

Across TCGA pan-cancer cohorts, RNA5SP33 RNA is linked to patient survival in 16 of 34 cancer types, making it the most broadly survival-associated RNA5SP33 data layer.

The strongest signal is observed in mesothelioma (MESO), where higher RNA5SP33 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNA5SP33 expression acts as an unfavorable survival marker, although some lineages such as STAD and BLCA show a favorable association.

MESO, CHOL, and STAD are the cancer types where RNA5SP33 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
MESO	OS	Tertile	All	0.084	0.560	<.001	63	view →
CHOL	OS	Tertile	III,IV	0.136	0.859	.003	45	view →
STAD	DFS	Median	IV	0.797	0.118	<.001	37	view →
DLBC	OS	Tertile	II,III,IV	0.096	0.865	<.001	36	view →
UCS	DFS	Tertile	IV	0.132	0.718	.002	36	view →
THCA	DFS	Tertile	III,IV	0.677	0.847	.009	27	view →
SKCM	DFS	Tertile	IV	0.040	0.620	.003	18	view →
ACC	OS	Tertile	IV	0.327	0.633	.045	18	view →
PRAD	OS	Tertile	All	0.649	0.914	<.001	18	view →
READ	DFS	Tertile	III,IV	0.255	0.757	.008	18	view →
LIHC	OS	Tertile	All	0.373	0.720	<.001	18	view →
BLCA	OS	Tertile	IV	0.745	0.556	.031	12	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 16 lineages.

RNA5SP33–MESO (OS)

Open the MESO breakdown →